share_log
Reuters ·  2024/12/30 13:16

Sangamo Therapeutics Inc: All Trial Participants Will Continue to Be Monitored as Planned During Transition Period

Sangamo Therapeutics Inc: 所有板块试验参与者将在过渡期间继续按照计划进行监测

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发